Morgan Freeman will take viewers on a global journey to meet with people from all cultures whose lives are shaped in surprising ways by different fundamental forces, this time exploring themes that unite us all. Each episode will explore a single fundamental force or topic, including love, belief, power, war and peace, rebellion and freedom.
In the first episode, Freeman travels around the world in search of a greater understanding of the concept of freedom. From solitary confinement and forced labor camps, to social taboos and laws that hinder speech and expression, freedom seems to be a constant struggle. As individuals and as entire nations, we are confronted with the question: Will we all ever be truly free?

Morgan Freeman travels the world to study the cycles of war and peace. From the ritualized combat of the sacred Tinku festival in Bolivia to Rwanda's post-genocide reconciliation program, this episode deals with humanity's enormous capacity for violence and the endless pursuit of harmony. Conflict can drive innovation, but is war necessary?

Can love change the world? Morgan Freeman is on a global quest to understand how this primal force binds us together as a species. From orphanages to battlefields, from arranged marriages to life on the streets, Freeman sees how love can be found in unexpected places and how this force inspires us all.

Can we bridge the divide between 'us' and 'them'? At a time when the whole world seems to be polarizing into irreconcilable camps, Morgan Freeman sets out on a journey in search of the forces that push us apart, from intolerance of differences to fear of outsiders, and the possibilities of coming together.

Can we find a way to distribute power so that everyone has their say? A U.S. president explains the challenges of making decisions that affect hundreds of millions of lives, and Freeman learns about an African woman who has created a society without men. He explores how the rise of the internet may fundamentally change how democracy works.

Valeant Pharmaceuticals was a multinational specialty pharmaceutical company based in Canada. It grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson. The company was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs, which led to an investigation by the U.S. Securities and Exchange Commission and caused its stock price to plummet more than 90 percent from its peak while its debt surpassed $30 billion.
Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.